MARKET

PRTA

PRTA

Prothena Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.72
-0.19
-1.47%
After Hours: 12.72 0 0.00% 16:45 08/07 EDT
OPEN
12.63
PREV CLOSE
12.91
HIGH
13.21
LOW
12.21
VOLUME
149.14K
TURNOVER
--
52 WEEK HIGH
17.63
52 WEEK LOW
6.71
MARKET CAP
507.67M
P/E (TTM)
-6.3133
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PRTA stock price target is 13.33 with a high estimate of 16.00 and a low estimate of 11.00.

EPS

PRTA News

More
Prothena EPS misses by $0.05, beats on revenue
Prothena (NASDAQ:PRTA): Q2 GAAP EPS of -$0.66 misses by $0.05. Revenue of $0.19M (+11.8% Y/Y) beats by $0.05M. Press Release
seekingalpha · 1d ago
Prothena (PRTA) Reports Q2 Loss, Tops Revenue Estimates
Prothena (PRTA) delivered earnings and revenue surprises of -3.13% and 11.43%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 1d ago
Prothena Reports Second Quarter 2020 Financial Results and Provides R&D Update
* Net cash used in operating and investing activities was $18.7 million in the second quarter and $41.9 million for the first six months of 2020; quarter-end cash and restricted cash position of $336.6 million provides funding to advance a broad pipeline DUBL
GlobeNewswire · 2d ago
Prothena Announces Phase 2 PASADENA Study Results to be Presented at International Congress of Parkinson’s Disease and Movement Disorders
* Phase 2 PASADENA Part 1 study results selected as an oral Top AbstractDUBLIN, Ireland, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation and a diverse pipeline of invest
GlobeNewswire · 3d ago
Were Hedge Funds Right About Selling Prothena Corporation plc (PRTA)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds
Insider Monkey · 5d ago
Prothena to Report Second Quarter 2020 Financial Results on August 6
DUBLIN, Ireland, July 30, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation and a diverse pipeleine of investigational therapeutics for neurodegenerative and rare peripheral amyloi
GlobeNewswire · 07/30 20:05
Analysts Estimate Prothena (PRTA) to Report a Decline in Earnings: What to Look Out for
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/28 16:33
Prothena (PRTA) Looks Good: Stock Adds 10.6% in Session
Zacks · 07/10 13:34

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About PRTA

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. The Company's pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion.
More

Webull offers kinds of Prothena Corporation PLC stock information, including NASDAQ:PRTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRTA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRTA stock methods without spending real money on the virtual paper trading platform.